15
Participants
Start Date
April 1, 2017
Primary Completion Date
June 1, 2019
Study Completion Date
June 1, 2019
[18F]-AzaFol
\[18F\]-AzaFol is a radiotracer produced at ETH Hönggerberg in a radiopharmaceutical GMP facility. The drug product is provided as sterile solution for intravenous injection in a glass vial containing 6 mL of formulated product, the maximal applicable dose being 600 MBq.
folarell
"For the purpose of this study only 1 mg folic acid (corresponding to 0.2 mL Folarell®) will be injected 5 min prior to \[18F\]-AzaFol. Due to this low dose of a single injection of folic acid it is unlikely that adverse events would occur.~Folarell® is a folic acid preparation for intravenous or intramuscular injection"
Lausanne University Hospitals, Lausanne
University Hospital, Zürich
OTHER
Cantonal Hospital of St. Gallen
OTHER
University of Lausanne Hospitals
OTHER